Patent Assignment
Reel/Frame 051491/0920
Change of Name
Recorded: 2020-01-07
Pages: 4
Assignor
ADARE DEVELOPMENT I., L.P.
Executed: 2019-11-25
Assignee
ADARE PHARMACEUTICALS US, L.P.
1200 LENOX DRIVE, SUITE 100, LAWRENCEVILLE, NEW JERSEY, 08648
Covered Property
(1)
Orally Administered Corticosteroid Compositions
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 4, 2018
From: ADARE PHARMACEUTICALS, INC.
To: ADARE DEVELOPMENT I, L.P,
Reel/Frame 047672/0450 →
Assignment of Assignor's Interest
Dec 5, 2018
From: PERRETT, STEPHEN; COHEN, FREDERIC JAY; VENKATESH, GOPI
To: EURAND, INC.
Reel/Frame 047678/0051 →
Change of Name
Dec 5, 2018
From: EURAND INCORPORATED
To: APTALIS PHARMATECH INC.
Reel/Frame 047720/0492 →
Change of Name
Dec 5, 2018
From: APTALIS PHARMATECH, INC.
To: ADARE PHARMACEUTICALS, INC.
Reel/Frame 047720/0520 →
Security Interest
Dec 18, 2018
From: ADARE DEVELOPMENT I, L.P.
To: BANK OF MONTREAL
Reel/Frame 047807/0967 →
Release of Security Interest Recorded at Reel/Frames 037246/0313, 047807/0967, 053474/0276
Sep 22, 2020
From: BANK OF MONTREAL, AS COLLATERAL AGENT
To: ADARE PHARMACEUTICALS, INC.; ADARE DEVELOPMENT I, L.P.; ADARE PHARMACEUTICALS USA, INC.
Reel/Frame 053852/0697 →
Change of Name
Apr 19, 2021
From: ADARE PHARMACEUTICALS US, L.P.
To: ELLODI PHARMACEUTICALS, L.P.
Reel/Frame 055966/0656 →